Hydroxychloroquine

Plaquenil (hydroxychloroquine) is a small molecule pharmaceutical. Hydroxychloroquine was first approved as Plaquenil on 1982-01-01. It is used to treat malaria, photosensitivity disorders, porphyria cutanea tarda, rheumatic diseases, and rheumatoid arthritis amongst others in the USA. It is known to target toll-like receptor 9 and toll-like receptor 7.